Jonathan Fassberg

Jonathan Fassberg is a visionary entrepreneur with over 20 years of experience in the biotechnology industry.

He is the Chief Executive Officer of The Trout Group, a premier investor relations firm in the life sciences sector, which has serviced over 250 public and private companies globally.

Recognizing the capital challenges faced by his clients, Jonathan established Trout Capital LLC in 2004 to provide financial advisory services.

His background includes serving as a sell-side analyst at a healthcare-focused investment bank and holding various sales and marketing positions at DuPont Pharma.

Jonathan holds a Bachelor of Science degree in biology and chemistry from The University of North Carolina – Chapel Hill and a Master of Business Administration degree in finance from NYU's Stern School of Business.

He is an active member of the Young Presidents Organization and currently serves as the Chapter Chair in Manhattan.

Additionally, Jonathan sits on the board of directors for the Carolina Center for Jewish Studies at UNC.

His expertise spans drug binding studies, finance, investor relations, and leadership roles across multiple organizations in the biotechnology and investment sectors.